FIELD: pharmaceuticals.
SUBSTANCE: invention relates to 1-phenyl-N-phenylpyrrolo[1,2-a]pyrazine-3-carboxamides of general formula (1):
,
where R can be hydrogen, (C1-C4)-alkyl or benzyl group, as well as their method of producing and method of treating disorders, mediated by their activity.
EFFECT: technical result is obtaining novel compounds having anxiolytic activity.
7 cl, 5 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
PYRROLO[1,2-A]PYRAZINE-CONTAINING LIGANDS OF THE 18 KDA TRANSLOCATOR PROTEIN WITH ANXIOLYTIC ACTIVITY | 2022 |
|
RU2812083C2 |
1-ARYLPYRROLO[1,2A]PYRAZINE-3-CARBOXAMIDES WITH NEUROPSYCHOTROPIC ACTIVITY | 2014 |
|
RU2572076C2 |
LIGANDS OF TRANSLOCATOR PROTEIN TSPO, HAVING ANTIDEPRESSANT AND NOOTROPIC ACTIVITY | 2015 |
|
RU2699568C2 |
PHARMACEUTICAL COMPOSITION BASED ON N-BENZYL-N-METHYL-1-PHENYLPYRROLO [1,2-A] PYRAZINE-3-CARBOXAMIDE | 2017 |
|
RU2689396C2 |
PHARMACEUTICAL COMPOSITION BASED ON N-BUTYL-N-METHYL-1-PHENYLPYRROLO[1,2-a]PYRAZINE-3-CARBOXAMIDE | 2023 |
|
RU2811453C1 |
TRIPEPTIDE HAVING NEUROPSYCHOTROPIC ACTIVITY | 2023 |
|
RU2823022C1 |
LEUCYLTRYPTOPHAN TSPO LIGANDS WITH ANXIOLYTIC ACTIVITY | 2020 |
|
RU2757476C2 |
TSPO DIPEPTIDE LIGANDS HAVING NEUROPSYCHOTROPIC ACTIVITY | 2018 |
|
RU2756772C2 |
SUBSTITUTED DIPEPTIDES WITH NEUROPSYCHOTROPIC ACTIVITY | 2014 |
|
RU2573823C2 |
2-SUBSTITUTED-1,2,4,5-TETRAHYDRO-3H-PYRROLO[1,2-a][1,4]DIAZEPIN-3-ONES | 2011 |
|
RU2472795C1 |
Authors
Dates
2020-10-13—Published
2018-11-13—Filed